We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments The reaction is catalysed in the opposite direction. Since quinolinate is synthesized from L-tryptophan in eukaryotes, but from L-aspartate in some prokaryotes, this is the first NAD+ biosynthesis enzyme shared by both eukaryotes and prokaryotes .
The taxonomic range for the selected organisms is: Homo sapiens The expected taxonomic range for this enzyme is: Bacteria, Eukaryota, Archaea
Synonyms
quinolinate phosphoribosyltransferase, quinolinic acid phosphoribosyltransferase, qaprtase, qprtase, nad pyrophosphorylase, quinolinate phosphoribosyl transferase, hqprtase, spnadc, quinolate phosphoribosyltransferase, quinolinate phosphoribosyltransferase 2,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
quinolinate phosphoribosyltransferase
-
quinolinic acid phosphoribosyltransferase
-
general stress protein 70
-
-
-
-
NAD pyrophosphorylase
-
-
-
-
nicotinate mononucleotide pyrophosphorylase (carboxylating) (EC 2.4.2.19)
-
-
-
-
nicotinate-nucleotide pyrophosphorylase (carboxylating)
-
-
-
-
nicotinate-nucleotide:pyrophosphate phospho-alpha-D-ribosyltransferase (decarboxylating)
-
-
-
-
pyrophosphorylase, nicotinate mononucleotide (carboxylating)
-
-
-
-
quinolinate phosphoribosyltransferase
quinolinate phosphoribosyltransferase (decarboxylating)
-
-
-
-
quinolinate phosphoribosyltransferase [decarboxylating]
-
-
-
-
quinolinic acid phosphoribosyltransferase
-
-
-
-
quinolinic phosphoribosyltransferase
-
-
-
-
quinolinate phosphoribosyltransferase
-
-
-
-
quinolinate phosphoribosyltransferase
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pentosyl group transfer
-
pentosyl group transfer
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
nicotinate-D-ribonucleotide:diphosphate phospho-alpha-D-ribosyltransferase (carboxylating)
The reaction is catalysed in the opposite direction. Since quinolinate is synthesized from L-tryptophan in eukaryotes, but from L-aspartate in some prokaryotes, this is the first NAD+ biosynthesis enzyme shared by both eukaryotes and prokaryotes [3].
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
phosphoribosyl diphosphate + quinolinic acid
nicotinate mononucleotide + diphosphate + CO2
-
-
-
r
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
beta-nicotinate D-ribonucleotide + diphosphate + CO2
-
-
-
?
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinate D-ribonucleotide + diphosphate + CO2
type II phosphoribosyltransfer followed by irreversible decarboxylation, involved in catabolism of quinolinic acid and in NAD+ de novo synthesis
-
-
ir
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinate D-ribonucleotide + diphosphate + CO2
additional information
?
-
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
-
-
-
?
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
-
-
-
-
?
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
6 mM MgCl2, pH7.2, 37°C, 0.3 mM quinolinic acid, HPLC-based assay: 7 microgram purified enzyme, 1 mM 5-phospho-alpha-D-ribose 1-diphosphate, 20 min, UV-based assay: 14 microgram purified enzyme, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, 30 min
HPLC-based assay: 254 nm (quantification of nicotinic acid mononucleotide and quinolinic acid), UV-based assay: 266 nm (quantification of nicotinic acid mononucleotide)
-
ir
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinate D-ribonucleotide + diphosphate + CO2
-
-
-
?
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinate D-ribonucleotide + diphosphate + CO2
-
-
-
ir
additional information
?
-
no detectable activity for mutants R161Q, R138Q, K171A, K171S, K139A, K139S, 6 mM MgCl2, pH7.2, 37°C, 0.3 mM quinolinic acid, UV-based assay: 14 microgram purified enzyme, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, 30 min
-
-
?
additional information
?
-
-
no detectable activity for mutants R161Q, R138Q, K171A, K171S, K139A, K139S, 6 mM MgCl2, pH7.2, 37°C, 0.3 mM quinolinic acid, UV-based assay: 14 microgram purified enzyme, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, 30 min
-
-
?
additional information
?
-
-
key enzyme in catabolism of quinolinate. Quinolinate acts as a most potent endogenous exitotoxin to neurons. Elevation of quinolinate levels in the brain has been linked to the pathogenesis of neurodegenerative disorders
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
phosphoribosyl diphosphate + quinolinic acid
nicotinate mononucleotide + diphosphate + CO2
-
-
-
r
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
beta-nicotinate D-ribonucleotide + diphosphate + CO2
-
-
-
?
pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinate D-ribonucleotide + diphosphate + CO2
type II phosphoribosyltransfer followed by irreversible decarboxylation, involved in catabolism of quinolinic acid and in NAD+ de novo synthesis
-
-
ir
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
additional information
?
-
-
key enzyme in catabolism of quinolinate. Quinolinate acts as a most potent endogenous exitotoxin to neurons. Elevation of quinolinate levels in the brain has been linked to the pathogenesis of neurodegenerative disorders
-
-
?
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
-
-
-
?
quinolinic acid + 5-phospho-alpha-D-ribose 1-diphosphate
nicotinic acid mononucleotide + diphosphate + CO2
-
-
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5-phospho-alpha-D-ribose 1-diphosphate
substrate inhibition, mixed inhibition (competitive and non-competitive) above 0.3 mM 5-phospho-alpha-D-ribose 1-diphosphate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acute Kidney Injury
De novo NAD+ biosynthetic impairment in acute kidney injury in humans.
Basal Ganglia Diseases
Immunohistochemical localization of quinolinic acid phosphoribosyltransferase in the human neostriatum.
Breast Neoplasms
Quinolinate Phosphoribosyltransferase Promotes Invasiveness of Breast Cancer Through Myosin Light Chain Phosphorylation.
Carcinoma
Determination of NAD pyrophosphorylase activity in biological samples.
Carcinoma, Hepatocellular
Biochemical mechanisms of resistance to tiazofurin.
Dementia
QPRTase modified N-doped carbon quantum dots: A fluorescent bioprobe for selective detection of neurotoxin quinolinic acid in human serum.
Glioma
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress.
Hepatitis C
Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection.
Huntington Disease
Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington's disease.
Huntington Disease
Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum.
Leukemia
Biochemical mechanisms of resistance to tiazofurin.
Leukemia, Myeloid, Acute
Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
Neoplasms
Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.
Neoplasms
Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
Nervous System Diseases
QPRTase modified N-doped carbon quantum dots: A fluorescent bioprobe for selective detection of neurotoxin quinolinic acid in human serum.
Nervous System Diseases
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue.
Neuroblastoma
Loss of the Chr16p11.2 ASD candidate gene QPRT leads to aberrant neuronal differentiation in the SH-SY5Y neuronal cell model.
Olivopontocerebellar Atrophies
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy.
Tuberculosis
Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamide.
Tuberculosis
Crystal structure of quinolinic acid phosphoribosyltransferase from Mmycobacterium tuberculosis: a potential TB drug target.
Tuberculosis
Crystal structure of Sus scrofa quinolinate phosphoribosyltransferase in complex with nicotinate mononucleotide.
Virus Diseases
Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection.
Wilms Tumor
Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0232
5-phospho-alpha-D-ribose 1-diphosphate
+/-0.0036 mM, wild-type, 0.3 mM quinolinic acid, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, 30 min, 37°C, KM for 5-phospho-alpha-D-ribose 1-diphosphate increases with decreasing quinolinic acid concentration
0.0216 - 0.319
quinolinic acid
0.0216
quinolinic acid
+/-0.003 mM, wild-type, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, 30 min, 37°C, affinity to quinolinic acid is independent of 5-phospho-alpha-D-ribose 1-diphosphate concentration
0.319
quinolinic acid
+/-0.060 mM, mutant R161A, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, 30 min, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
5-phospho-alpha-D-ribose 1-diphosphate
additional information
5-phospho-alpha-D-ribose 1-diphosphate
Vmax = 0.93(+/-0.03) microM/min, wild-type, 0.3 mM quinolinic acid, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, Vmax increases with increasing 5-phospho-alpha-D-ribose 1-diphosphate concentrations up to 5 mM
additional information
5-phospho-alpha-D-ribose 1-diphosphate
-
Vmax = 0.93(+/-0.03) microM/min, wild-type, 0.3 mM quinolinic acid, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, Vmax increases with increasing 5-phospho-alpha-D-ribose 1-diphosphate concentrations up to 5 mM
additional information
quinolinic acid
Vmax = 0.71(+/-0.0) microM/min, mutant R161A, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm
additional information
quinolinic acid
-
Vmax = 0.71(+/-0.0) microM/min, mutant R161A, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm
additional information
quinolinic acid
Vmax = 1.19(+/-0.05) microM/min, wild-type, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm
additional information
quinolinic acid
-
Vmax = 1.19(+/-0.05) microM/min, wild-type, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.09
wild-type, 0.1 mM 5-phospho-alpha-D-ribose 1-diphosphate, UV-based assay measuring nicotinic acid mononucleotide formation at 266 nm, 30 min, 37°C, same order of magnitude as bacterial enzymes, 100% relative activity
0.0133
-
enzyme from liver
0.0187
-
enzyme from brain
additional information
mutant R102A and R102Q, 10% remaining activity
additional information
-
mutant R102A and R102Q, 10% remaining activity
additional information
mutant R161A, 20% remaining activity
additional information
-
mutant R161A, 20% remaining activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
UniProt
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
metabolism
key enzyme in the de novo nicotinamide adenine dinucleotide synthesis pathway
physiological function
interacts with active-caspase-3, depletion of quinolinate phosphoribosyltransferase protein increases intracellular caspase-3 activity, quinolinate phosphoribosyltransferase-depleted cells are highly sensitive to spontaneous cell death, quinolinate phosphoribosyltransferase protein prevents spontaneous cell death through inhibition of overproduction of active-caspase-3, identified as a caspase-3 binding protein, not a substrate for caspase-3
physiological function
the enzyme is essential for maintaining the homeostasis of quinolinic acid in the brain
physiological function
the enzyme inhibits hepatitis C virus replication via reduction of cellular lipogenesis
physiological function
the enzyme with anti-apoptotic properties is a direct target gene of Wilms' tumor gene 1 in leukemic cells. Enzyme overexpression in K-562 leukemic cells increases resistance to imatinib
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NADC_HUMAN
297
0
30846
Swiss-Prot
Secretory Pathway (Reliability: 1 )
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
167000
-
sucrose density gradient centrifugation
34000
-
5 * 34000, SDS-PAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
homohexamer
-
gel filtration
pentamer
-
5 * 34000, SDS-PAGE
?
x * 35000, SDS-PAGE
hexamer
x-ray crystallography
hexamer
-
x-ray crystallography
hexamer
according to gel filtration, 3 canonical (AB) dimers (formed by two-fold rotation placing N-terminus of monomer A next to C-terminus of monomer B) related to each other by 3-fold rotation axis, hexameric D3 symmetry, active sites in close proximity at interface between monomers A and monomers B
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
apoenzyme and in complex with phthalic acid, sitting drop vapor diffusion method, using 50 mM MES pH 6.5, 0.1 M NaH2PO4, 0.1 M K H2PO4, and 1.6-2.1 M NaCl
apoenzyme and in complex with quinolinic acid or nicotinic acid mononucleotide, hanging drop vapor diffusion method, using
PDB code: 2jbm (apo-hQPRTase), alpha/beta barrel fold (12 beta strands + 11 alpha helices) with N-terminal domain (residues 1-112, 279-291) and C-terminal domain (residues 113-278), similar to bacterial QPRTases (PDB: 1x1o), active site at alpha/beta open sandwich structure that faces an alpha/beta barrel of the adjacent subunit harbouring the quinolinic acid binding site (Arg102, Arg138, Arg161, Lys139, Lys171, pocket at the centre of the barrel), space group P2(1)2(1)2(1), unit-cell parameters: a = 111.5 A, b = 179.5 A, c = 194.7 A, 12 monomers in asymmetric unit arranged as 2 hexamers of D3 symmetry, sitting-drop vapour diffusion: 5 days, 20°C, 2 microlitre protein solution (10 mg/ml, pH7.5) + 2 microlitre precipitant (0.6 M potassium/sodium tartrate, 0.1 M sodium HEPES pH7.6), resolution of 2 A, phase determination using multiple wavelength anomalous diffraction on crystals of the Se-Met variant
hanging-drop vapour-diffusion method, PEG MME 2K
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
K139A
inactive, K139 is part of quinolinic acid binding site
K139S
inactive, K139 is part of quinolinic acid binding site
K171A
inactive, K171 is part of quinolinic acid binding site
K171S
inactive, K171 is part of quinolinic acid binding site
R102A
10% remaining activity, R102 is part of quinolinic acid binding site, denotes from the other subunit in the canonical dimer
R102Q
10% remaining activity, R102 is part of quinolinic acid binding site, denotes from the other subunit in the canonical dimer
R138Q
inactive, R138 is part of quinolinic acid binding site
R161Q
inactive, R161 is part of quinolinic acid binding site
R161A
20% remaining activity, R161 is part of quinolinic acid binding site and important for substrate binding
R161A
the mutation abolishes substrate binding and enzyme activity with a 20% capacity of wild type enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ammonium sulfate precipitation, dye ligand chromatography (Blue-Sepharose), ion exchange chromatography
nickel affinity chromatography, TEV protease cleavage followed by nickel affinity chromatography, gel filtration, selenomethionine variant of hQPRTase purified in presence of 5 mM beta-mercaptoethanol
nickel Sepharose column chromatography and Superdex 200 gel filtration
immobilized metal ion affinity chromatography (Ni2+), gel filtration
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expressed in Escherichia coli BL21(DE3) cells
expressed in Escherichia coli BL21(DE3)-RIPL Codon Plus
in pEHISTEV (pBS-hQPRT as template) for expression in Escherichia coli BL21(DE3) or mutagenesis, expression with N-terminal hexa-His tag and TEV protease cleavage site, two extra N-terminal residues (Gly, Ala) remain after removal of hexa-His tag
expression in Escherichia coli
-
His-tagged protein expressed in Escherichia coli C41 (DE3)
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
overexpression of Wilms' tumor gene 1 in hematopoietic progenitor cells and cell lines results in an increase of enzyme expression
the enzyme is significantly reduced in livers of patients with persistent hepatitis C virus infection
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Okuno, E.; White, R.J.; Schwarcz, R.
Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain
J. Biochem.
103
1054-1059
1988
Homo sapiens
brenda
Fukuoka, S.I.; Nyaruhucha, C.M.; Shibata, K.
Characterization and functional expression of the cDNA encoding human brain quinolinate phosphoribosyltransferase
Biochim. Biophys. Acta
1395
192-201
1998
Homo sapiens
brenda
Liu, H.; Woznica, K.; Catton, G.; Crawford, A.; Botting, N.; Naismith, J.H.
Structural and kinetic characterization of quinolinate phosphoribosyltransferase (hQPRTase) from Homo sapiens
J. Mol. Biol.
373
755-763
2007
Homo sapiens (Q15274), Homo sapiens
brenda
Kang, G.B.; Kim, M.K.; Youn, H.S.; An, J.Y.; Lee, J.G.; Park, K.R.; Lee, S.H.; Kim, Y.; Fukuoka, S.; Eom, S.H.
Crystallization and preliminary X-ray crystallographic analysis of human quinolinate phosphoribosyltransferase
Acta Crystallogr. Sect. F
67
38-40
2011
Homo sapiens
brenda
Ishidoh, K.; Kamemura, N.; Imagawa, T.; Oda, M.; Sakurai, J.; Katunuma, N.
Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD(+) synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3
Biochim. Biophys. Acta
1803
527-533
2010
Homo sapiens (Q15274)
brenda
Malik, S.S.; Patterson, D.N.; Ncube, Z.; Toth, E.A.
The crystal structure of human quinolinic acid phosphoribosyltransferase in complex with its inhibitor phthalic acid
Proteins
82
405-414
2014
Homo sapiens (Q15274), Homo sapiens
brenda
Youn, H.S.; Kim, T.G.; Kim, M.K.; Kang, G.B.; Kang, J.Y.; Lee, J.G.; An, J.Y.; Park, K.R.; Lee, Y.; Im, Y.J.; Lee, J.H.; Eom, S.H.
Structural insights into the quaternary catalytic mechanism of hexameric human quinolinate phosphoribosyltransferase, a key enzyme in de novo NAD biosynthesis
Sci. Rep.
6
19681
2016
Homo sapiens (Q15274), Homo sapiens
brenda
Ullmark, T.; Montano, G.; Jaervstrat, L.; Jernmark Nilsson, H.; Hakansson, E.; Drott, K.; Nilsson, B.; Vidovic, K.; Gullberg, U.
Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms tumor gene 1 (WT1) protein in leukemic cells
Biochem. Biophys. Res. Commun.
482
802-807
2017
Homo sapiens (Q15274)
brenda
Wang, Z.; Gao, Y.; Zhang, C.; Hu, H.; Guo, D.; Xu, Y.; Xu, Q.; Zhang, W.; Deng, S.; Lv, P.; Yang, Y.; Ding, Y.; Li, Q.; Weng, C.; Chen, X.; Gong, S.; Chen, H.; Niu, J.; Tang, H.
Quinolinate phosphoribosyltransferase is an antiviral host factor against hepatitis C virus infection
Sci. Rep.
7
5876
2017
Homo sapiens (Q15274), Homo sapiens
brenda